Stay updated on CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoChange DetectedThe page indicates a termination of a previous status and notes a change in business objectives, with a new date of April 17, 2025, replacing an earlier date of February 19, 2025.SummaryDifference2%
- Check22 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 19, 2025, while a previous date of March 25, 2025, has been removed.SummaryDifference1.0%
- Check73 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a future date has been added.SummaryDifference6%
- Check87 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-93269 in Relapsed/Refractory Multiple Myeloma Clinical Trial page.